BDO provided lead advisory, debt advisory and financial and tax due diligence services to Sovereign Capital on its acquisition of Xendo B.V., a specialist provider of regulatory affairs and pharmacovigilance services to the life sciences industry.
Founded in 1990 and employing over 140 experienced and highly educated professionals, Xendo operates from three countries in Europe (Netherlands, Germany and UK) and in Japan. The business is focused on the complex regulatory compliance requirements of its customers; it provides regulatory affairs compliance, validation and pharmacovigilance consulting and outsourced services to life sciences companies throughout the life cycle of their products.
"The BDO team were not only able to combine their deep knowledge of the Pharma Sector together with the invaluable expertise of their Debt Advisory team but also a strong European presence in order to provide us with the complete buy-side offering including financial and tax due diligence".
Jonathan Kay, Investment Director, Sovereign Capital